|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|---|
| Cash | ||||||
| Prepaid expenses | ||||||
| Marketable securities held in Trust Account | ||||||
| Total current assets | ||||||
| Total non-current assets | ||||||
| TOTAL ASSETS | ||||||
| Accounts payable and accrued expenses | ||||||
| Due to related parties | ||||||
| Over-allotment liability | ||||||
| Due to a related party | ||||||
| Promissory note - a related party | ||||||
| Total current liabilities | ||||||
| Total Liabilities | ||||||
| Ordinary shares subject to possible redemption, $0.0001 par value, 500,000,000 shares authorized, 5,595,000 and 5,595,000 shares subject to possible redemption as of September 30, 2026 and December 31, 2025, respectively | ||||||
| Ordinary shares, $0.0001 par value, 500,000,000 shares authorized, 1,708,575 and 1,708,575 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively | ||||||
| Additional paid-in capital | ||||||
| Total Shareholders’ Equity | ||||||
| TOTAL LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ EQUITY |
Loading...